1. Home
  2. CAC vs PHAR Comparison

CAC vs PHAR Comparison

Compare CAC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$56.45

Market Cap

923.2M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.15

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
PHAR
Founded
1875
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.2M
793.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CAC
PHAR
Price
$56.45
$10.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $47.00
$38.33
AVG Volume (30 Days)
★ 69.0K
34.1K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
★ 3.51%
N/A
EPS Growth
★ 6.08
N/A
EPS
★ 2.64
N/A
Revenue
★ $41,739,000.00
N/A
Revenue This Year
$19.15
$10.04
Revenue Next Year
$6.05
$2.51
P/E Ratio
★ $21.25
$3,041.22
Revenue Growth
★ 16.96
N/A
52 Week Low
$35.00
$9.62
52 Week High
$60.59
$21.34

Technical Indicators

Market Signals
Indicator
CAC
PHAR
Relative Strength Index (RSI) 42.52 38.04
Support Level $54.42 $9.62
Resistance Level $56.10 $11.60
Average True Range (ATR) 1.29 0.47
MACD -0.12 -0.03
Stochastic Oscillator 21.25 9.45

Price Performance

Historical Comparison
CAC
PHAR

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: